Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial
Antônio Fagundes, Christian T. Ruff, David A. Morrow, Sabina A. Murphy, Michael G. Palazzolo, Cathy Z. Chen, Petr Jarolı́m, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano
Topics & Concepts
MedicineMaceAtrial fibrillationInternal medicineInterquartile rangeTIMIStroke (engine)Neutrophil to lymphocyte ratioHazard ratioCardiologyWarfarinMyocardial infarctionLymphocytePercutaneous coronary interventionConfidence intervalMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesInflammatory Biomarkers in Disease PrognosisVenous Thromboembolism Diagnosis and Management